News Channels

27 Jun 2017 Chromocell Announces Initiation of Multiple Ascending Doses Portion of Phase 1 Clinical Trial
27 Jun 2017 MabVax Therapeutics Commences Patient Dosing in MVT-1075 Radioimmunotherapy Phase 1 Clinical Trial for the Treatment of Pancreatic, Colon and Lung Cancers
27 Jun 2017 Araclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
27 Jun 2017 Trovagene Announces Submission of Investigational New Drug Application to Initiate Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia
27 Jun 2017 Ra Pharmaceuticals Announces Initial Data from Phase 2 Clinical Trial of RA101495 in PNH
27 Jun 2017 NantCell, a NantWorks Company, to Acquire Altor BioScience
27 Jun 2017 Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection
27 Jun 2017 Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint
27 Jun 2017 Merck Provides Update on REVEAL Outcomes Study of Anacetrapib
27 Jun 2017 GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial
27 Jun 2017 GSK starts phase III study with mepolizumab in patients with nasal polyps
27 Jun 2017 Ablynx achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA
27 Jun 2017 U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients
27 Jun 2017 Atossa Genetics Receives Positive Safety Committee Assessment of First Cohort Receiving Oral Formulation of Endoxifen in Phase 1 Dose Escalation Study
27 Jun 2017 Rhythm and Camurus Announce Positive Initial Data for Extended-Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity
27 Jun 2017 Semnur Pharmaceuticals, Inc., Announces Successful Phase 1 / 2 Trial in Patients with Radicular Pain for Its Lead Product, SP-102
27 Jun 2017 Boston Biomedical Announces Unblinding of the Phase 3 Trial in Patients with Advanced Gastric/GEJ Cancer
27 Jun 2017 Enanta Announces New Data on EDP-938, a Novel Non-Fusion Inhibitor of Respiratory Syncytial Virus (RSV), at the XIX International Symposium on Respiratory Viral Infections
27 Jun 2017 ImmunoGen Presents Data from Phase I Study of IMGN779 in Acute Myeloid Leukemia
27 Jun 2017 Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top